These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31327116)

  • 21. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
    Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
    Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left atrial diameter in heart failure with left ventricular preserved, mid-range, and reduced ejection fraction.
    Zhu N; Chen H; Zhao X; Ye F; Jiang W; Wang Y
    Medicine (Baltimore); 2019 Nov; 98(48):e18146. PubMed ID: 31770253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathophysiology of heart failure with preserved ejection fraction.
    Borlaug BA
    Nat Rev Cardiol; 2014 Sep; 11(9):507-15. PubMed ID: 24958077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data.
    Beldhuis IE; Streng KW; Ter Maaten JM; Voors AA; van der Meer P; Rossignol P; McMurray JJ; Damman K
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28209765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes in patients with critical limb ischemia and heart failure with preserved or reduced ejection fraction.
    Khaira KB; Brinza E; Singh GD; Amsterdam EA; Waldo SW; Tong K; Pandya K; Laird JR; Armstrong EJ
    Vasc Med; 2017 Aug; 22(4):307-315. PubMed ID: 28693409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction.
    Kresoja KP; Lauten A; Orban M; Rommel KP; Alushi B; Besler C; Braun D; Unterhuber M; Stangl K; Landmesser U; Massberg S; Thiele H; Hausleiter J; Lurz P
    Eur J Heart Fail; 2020 Oct; 22(10):1817-1825. PubMed ID: 32741057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Heart failure with preserved left ventricular ejection fraction].
    Maeder MT; Rickli H
    Praxis (Bern 1994); 2013 Oct; 102(21):1299-307. PubMed ID: 24129298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and Design of the Multicenter Trial on Japan Working Group on the Effects of Angiotensin Receptor Blockers Selection (Azilsartan vs. Candesartan) on Diastolic Function in the Patients Suffering from Heart Failure with Preserved Ejection Fraction: J-TASTE Trial.
    Takahama H; Asakura M; Abe Y; Ajioka M; Aonuma K; Anzai T; Hayashi T; Hiramitsu S; Kawai H; Kioka H; Kimura K; Lim YJ; Matsuoka K; Motoki H; Nagata Y; Nakamura S; Ohte N; Ozaki Y; Sasaoka T; Tamaki S; Hamasaki T; Kitakaze M;
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):381-388. PubMed ID: 29974299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction.
    Voors AA; Shah SJ; Bax JJ; Butler J; Gheorghiade M; Hernandez AF; Kitzman DW; McMurray JJV; Wirtz AB; Lanius V; van der Laan M; Solomon SD
    Eur J Heart Fail; 2018 Nov; 20(11):1601-1610. PubMed ID: 30225882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.
    Chen X; Savarese G; Dahlström U; Lund LH; Fu M
    Clin Res Cardiol; 2019 Dec; 108(12):1394-1405. PubMed ID: 30980205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical Treatment for Heart Failure.
    Lin X; Fang L
    Adv Exp Med Biol; 2020; 1177():269-295. PubMed ID: 32246448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
    Saksena S; Slee A; Saad M
    J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and safety of transcatheter aortic valve replacement in elderly people with severe aortic stenosis with different types of heart failure.
    Dong M; Wang L; Tse G; Dai T; Wang L; Xiao Z; Liu T; Ren F
    BMC Cardiovasc Disord; 2023 Jan; 23(1):34. PubMed ID: 36653770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction.
    He X; Dong B; Xue R; Zhao J; Wu Z; Wu Y; Zhou Y; Wu D; Dong Y; He J; Liu C
    ESC Heart Fail; 2021 Aug; 8(4):3248-3256. PubMed ID: 34076960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Heart failure with preserved left ventricular ejection fraction].
    Petutschnigg J; Edelmann F
    Internist (Berl); 2019 Sep; 60(9):925-942. PubMed ID: 31432196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives.
    Kessler EL; Oerlemans MIFJ; van den Hoogen P; Yap C; Sluijter JPG; de Jager SCA
    J Cardiovasc Transl Res; 2021 Feb; 14(1):63-74. PubMed ID: 32444946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.
    Si J; Ding Z; Hu Y; Zhang X; Zhang Y; Cao H; Liu Y
    J Cardiol; 2024 Apr; 83(4):250-257. PubMed ID: 37802201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.